The Canadian cannabis giant reported roughly CA$60 million ($48.2 million) in total net revenue, representing a year-over-year decline of 11%. Adjusted EBITDA came in negative at CA$12,1 million, showing a 79% improvement from a CA$58.1 million loss in the prior year's period.
Moreover, the company posted a fiscal first-quarter loss of CA$11.9 million, or 6 cents a share, improving from a loss of 90 cents a share a year ago.
While the company's stock declined in after-hours on the heels of the disclosure, it gained some of its value during the regular session. Currently, it trades 3.72% lower at $7.2 per share.
Cantor Fitzgerald analyst Pablo Zuanic raised the price target on Aurora's stock to CA$10.75 from CA$9.60, after increasing sales estimates.
Moving Away From Value End In Domestic Rec